Skip Navigation


Human Molecular Genetics Advance Access originally published online on December 5, 2005
Human Molecular Genetics 2006 15(2):273-285; doi:10.1093/hmg/ddi443
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
15/2/273    most recent
ddi443v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Apostol, B. L.
Right arrow Articles by Thompson, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Apostol, B. L.
Right arrow Articles by Thompson, L. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity

Barbara L. Apostol1, Katalin Illes1, Judit Pallos2, Laszlo Bodai2, Jun Wu3, Andrew Strand4, Erik S. Schweitzer5, James M. Olson4, Aleksey Kazantsev6, J. Lawrence Marsh2,{dagger} and Leslie Michels Thompson1,*,{dagger}

1Department of Psychiatry and Human Behavior and 2Developmental Biology Center and Department of Developmental and Cell Biology, University of California, Irvine, CA 92697, USA, 3Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, USA, 4Division of Hematology/Oncology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98195, USA, 5Department of Physiological Chemistry and Brain Research Institute, UCLA School of Medicine, Los Angeles, CA90095, USA and 6Center for Aging and Neurodegeneration, Massachusetts General Hospital, Building 114-3300, 16th Street, Charlestown, MA 02129, USA

* To whom correspondence should be addressed at: Gillespie 2121, University of California, Irvine, CA 92697-4260. Tel: +1 949 824 6756. Email: lmthompson{at}uci.edu

Received September 23, 2005; Accepted November 27, 2005

Huntington's disease (HD) is a devastating neurodegenerative disorder caused by an expanded polyglutamine (polyQ) tract within the huntingtin protein (Htt). Identifying the pathways that are altered in response to the mutant protein is crucial for understanding the cellular processes impacted by the disease as well as for the rational development of effective pharmacological interventions. Here, expression profiling of a cellular HD model identifies genes that implicate altered mitogen-activated protein kinase (MAPK) signaling. Targeted biochemical studies and pharmacological modulation of these MAPK pathways suggest that mutant Htt affects signaling at upstream points such that both ERK and JNK are activated. Modulation of the ERK pathway suggests that this pathway is associated with cell survival, whereas inhibition of JNK was found to effectively suppress pathogenesis. These studies suggest that pharmacological intervention in MAPK pathways, particularly at the level of ERK activation, may be an appropriate approach to HD therapy.

{dagger} These authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
D. S. Verbeek, J. Goedhart, L. Bruinsma, R. J. Sinke, and E. A. Reits
PKC{gamma} mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling
J. Cell Sci., July 15, 2008; 121(14): 2339 - 2349.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
E. Roze, S. Betuing, C. Deyts, E. Marcon, K. Brami-Cherrier, C. Pages, S. Humbert, K. Merienne, and J. Caboche
Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death
FASEB J, April 1, 2008; 22(4): 1083 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Giorgini, T. Moller, W. Kwan, D. Zwilling, J. L. Wacker, S. Hong, L.-C. L. Tsai, C. S. Cheah, R. Schwarcz, P. Guidetti, et al.
Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment
J. Biol. Chem., March 21, 2008; 283(12): 7390 - 7400.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J.-C. Lievens, M. Iche, M. Laval, C. Faivre-Sarrailh, and S. Birman
AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease
Hum. Mol. Genet., March 15, 2008; 17(6): 882 - 894.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Varma, R. Cheng, C. Voisine, A. C. Hart, and B. R. Stockwell
Inhibitors of metabolism rescue cell death in Huntington's disease models
PNAS, September 4, 2007; 104(36): 14525 - 14530.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
E. Scappini, T.-W. Koh, N. P. Martin, and J. P. O'Bryan
Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase
Hum. Mol. Genet., August 1, 2007; 16(15): 1862 - 1871.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M.-H. Liang and D.-M. Chuang
Regulation and Function of Glycogen Synthase Kinase-3 Isoforms in Neuronal Survival
J. Biol. Chem., February 9, 2007; 282(6): 3904 - 3917.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.